Title
Category
Credits
Event date
Cost
$0.00
This activity was presented at VAM2020 as part of Scientific Session 9.
$0.00
This activity was presented at VAM2020 as part of Scientific Session 9.
$0.00
This activity was presented at VAM2020 as part of Scientific Session 9.
$0.00
This activity was presented at VAM2020 as part of Scientific Session 9.
- Venous Disease
- Deep Venous Disease
$0.00
Efthymios Avgerinos, MD, University of Pittsburgh Medical Center
- Dialysis Access
- Open Creation
$0.00
Bradley Bowles, MD, Michael Williams, MD, and Matthew R. Smeds, MD
- Acute Upper Extremity Ischemia
- Basic and Translational Research
- Atherosclerosis Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 1: Arterial Remodeling and Discovery Science for Venous Disease.Knowledge StrategyWith a better understanding of the mechanisms governing arteriogenesis, we may find pharmacological targets that could enhance collateral artery formation. This could lead to a pharmacological therapy that effectively increases blood flow to an ischemic tissue which would revolutionize management of patients with arterial occlusive diseases.
- Basic and Translational Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 1: Arterial Remodeling and Discovery Science for Venous Disease.Knowledge StrategyThis research is demonstrating the efficacy of a novel compound that may help to reduce neointimal hyperplasia following vascular intervention.Professional Practice GapThe analogue discussed in this abstract may provide durable patency following vascular interventions.
- Basic and Translational Research
- Neo Intimal Hyperplasia
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 1: Arterial Remodeling and Discovery Science for Venous Disease.Knowledge StrategyThe results of this project, and subsequent projects it leads to, can lead to a paradigm shifting technology that can completely alter how we treat vascular diseases, improving outcomes and the overall cost of cardiovascular disease.
- Basic and Translational Research
- Atherosclerosis Research
$0.00
This activity was presented at 2020 VRIC as part of Abstract Session 1: Arterial Remodeling and Discovery Science for Venous Disease.Knowledge StrategyPDL1 antibody increased T-helper cells and decreased Treg, consistent with increase of inflammation. Moreover, PDL1 antibody reduced vascular wall thickening during AVF maturation. These results indicate that PDL1 have a critical role to cause inflammation during AVF maturation and might be a therapeutic target to improve AVF success.